InsidersTradesSigma
Follow the Allergy Therapeutics Plc share price and the full management transaction log of the company, a listed issuer based in United Kingdom. Shares trade on UK GB, under the supervision of RNS (LSE). Market capitalisation: €449.6m. The latest transaction was reported on 15 January 2025 (Purchase). Among the most active insiders: ZQ Capital Management Limited. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Allergy Therapeutics Plc is a company focused on developing immunotherapy treatments for allergies. It is listed on the London Stock Exchange.